ST Pharm Co.,Ltd. (KOSDAQ:237690)
152,300
+5,200 (3.54%)
Feb 27, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 3.16 trillion as of February 27, 2026. Its market cap has increased by 95.53% in one year.
Market Cap
3.16T
Enterprise Value
3.12T
Revenue
318.32B
Ranking
n/a
PE Ratio
84.84
Stock Price
152,300.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 3.16T, an increase of 250.79%. That is a compound annual growth rate of 13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.16T | 28.23% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.75T |
| Celltrion | 52.97T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 17.61T |
| PharmaResearch | 3.63T |
| OliX Pharmaceuticals | 3.22T |
| Celltrion Pharm | 3.17T |
| Hanall Biopharma | 3.10T |